Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aptalis Pharma

Aptalis Pharma
1982 FOUNDED
M&A STATUS
901-1000 EMPLOYEES
M&A LATEST DEAL TYPE
13 FINANCING ROUNDS
6 INVESTMENTS
Description

Manufacturer of pharmaceutical products for the treatment of gastrointestinal diseases. The company offers therapies for cystic fibrosis and gastrointestinal disorders. It also offers pharmaceutical products for exocrine pancreatic insufficiency.

Formerly Known As
Axcan Intermediate Holdings
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 597 Laurier Boulevard
  • Mont Saint Hilaire, Quebec J3H 6C4
  • Canada

Aptalis Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aptalis Pharma‘s full profile, request access.

Request full access to PitchBook

Aptalis Pharma Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Representaciones e Investigaciones Médicas Corporate Backed or Acquired Mexico City, Mexico 0000 000000&0
00000 000000000000 Formerly VC-backed Bridgewater, NJ 0000 00000 000000&0
00000000 000000000 Corporation Norcross, GA 0
0000000 0000000 Formerly PE-Backed Philadelphia, PA 0000 00000 000000000 00000
000000 00000000000 Venture Capital-Backed Durham, NC 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Aptalis Pharma Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000000000 01-Jul-2011 0000000000 0000 Pharmaceuticals
000000 11-Feb-2011 0000000000 00000 Pharmaceuticals 00000 0000000 00
000000000000 00000 07-Nov-2001 000000000000000000 0000 Pharmaceuticals 0000 00000000
00000000000 10-Sep-1999 000000000000000000 00000 Pharmaceuticals 0000 00000000
Bonne Sante 31-Aug-1999 Merger/Acquisition Consulting Services (B2B)
To view this company’s complete investment and acquisition history, request access »

Aptalis Pharma Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00000 31-Aug-1999 000000000000000000 Completed
  • 0000000 000000
Althin Biopharm 19-Dec-1995 Joint Venture Completed
  • 2 buyers
To view this company’s complete exits history, request access »

Aptalis Pharma Subsidiaries (1)

Company Name Industry Location Founded
0000 0000000000000 Pharmaceuticals San Diego, CA 0000
To view this company’s complete subsidiary history, request access »

Aptalis Pharma Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Aptalis Pharma‘s full profile, request access.

Request full access to PitchBook

Aptalis Pharma Executive Team (15)

Name Title Board
Seat
Contact
Info
David Mims Executive Vice President, Board Member & Chief Operating Officer
Alexandre LeBeaut MD Senior Vice President & Chief Scientific Officer
Theresa Stevens JD Executive, Chief Corporate Development & Senior Vice President
Keriann Masters Executive, Business Development
Robert Becker Executive, Chief Research Officer

8 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Aptalis Pharma Board Members (5)

Name Representing Role Since Contact
Info
000000 000000 Self Board Member 000 0000

4 Former Board Members

You’re viewing 1 of 5 board members. Get the full list »